A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2006
12/13/2006	EP1731147A1 External preparation
12/13/2006	EP1731143A1 Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure
12/13/2006	EP1731142A1 Specific time-delayed burst profile delivery system
12/13/2006	EP1731141A2 Gastric acid secretion inhbiting compositon
12/13/2006	EP1731140A2 Medicinal aerosol formulation
12/13/2006	EP1731139A1 S/o type pharmaceutical preparation and process for producing the same
12/13/2006	EP1731138A1 Fine dispersion of sparingly soluble drug and process for producing the same
12/13/2006	EP1731134A1 Functional powders
12/13/2006	EP1730217A2 Granule
12/13/2006	EP1730216A1 Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
12/13/2006	EP1730214A1 Matrix of polysaccharide that is modified under an electron beam by a functional oganosilicon compound
12/13/2006	EP1730199A1 Native plant cell wall compositions and methods of use
12/13/2006	EP1730077A1 Embolization
12/13/2006	EP1729829A1 Compositions for repairing bone and methods for preparing and using such compositions
12/13/2006	EP1729819A1 X-ray visible drug delivery device
12/13/2006	EP1729812A1 Stable pharmaceutical composition comprising an ace inhibitor
12/13/2006	EP1729811A1 Cream-gel containing ivermectin
12/13/2006	EP1729810A2 Methods of reducing aggregation of il-1ra
12/13/2006	EP1729797A1 Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
12/13/2006	EP1729786A2 Administration of cisplatin by inhalation
12/13/2006	EP1729779A2 Coating method
12/13/2006	EP1729778A2 Pharmaceutical preparation containing drospirenone for application to the skin
12/13/2006	EP1729769A1 Compositions with reduced hepatotoxicity
12/13/2006	EP1729768A2 Immune response modifier formulations and methods
12/13/2006	EP1729767A1 Combination of a heterocyclic compound and an antioxidant and use thereof for treating obesity
12/13/2006	EP1729766A1 Pharmaceutical formulation
12/13/2006	EP1729748A1 Microemulsion preconcentrate comprising a renin inhibitor
12/13/2006	EP1729746A2 Means for transdermal administration of nicotine
12/13/2006	EP1729745A1 Method for producing cs particles and microcapsules using porous templates, cs particles and microcapsules, and the use thereof
12/13/2006	EP1729744A1 Pharmaceutical formulations
12/13/2006	EP1729743A1 Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
12/13/2006	EP1729742A1 Enteric coatings for orally ingestible substrates
12/13/2006	EP1729741A2 Polymeric drug delivery system for hydrophobic drugs
12/13/2006	EP1729740A2 PHARMACEUTICAL DOSAGE FORMS HAVING IMMEDIATE RELEASE AND/OR CONTROLLED RELEASE PROPERTIES THAT CONTAIN A GABA<SB>B</SB> RECEPTOR AGONIST
12/13/2006	EP1729739A1 Process for preparing a solid pharmaceutical composition
12/13/2006	EP1729738A1 Polymeric compositions and dosage forms comprising the same
12/13/2006	EP1729737A1 Disintegrating tablets comprising licarbazepine
12/13/2006	EP1729736A2 Galenic formulations of organic compounds
12/13/2006	EP1729735A2 Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
12/13/2006	EP1729734A2 Spray dried pharmaceutical compositions
12/13/2006	EP1729733A1 Hydrogel microspheres with improved release profile
12/13/2006	EP1729732A1 Anionic hyrdogel matrices with ph dependent modified release as drug carriers
12/13/2006	EP1729731A1 Particulates
12/13/2006	EP1729730A2 Tamper resistant dosage form comprising an adsorbent and an adverse agent
12/13/2006	EP1729729A2 Pharmaceutical compositions
12/13/2006	EP1729728A1 Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
12/13/2006	EP1729727A2 Imroved formulations of 6-mercaptopurine
12/13/2006	EP1729726A1 Application of a bioactive agent to a delivery substrate
12/13/2006	EP1729725A2 Pharmaceutical ocular preparations suitable for the treatment of the ocular surface and related disorders/diseases
12/13/2006	EP1729724A1 Inhalent formulation containing sulfoalkyl ether gamma-cyclodextryn and corticosteroid
12/13/2006	EP1729714A1 Pharmaceutical dispensing apparatus and method
12/13/2006	EP1729678A1 Load bearing biocompatible device
12/13/2006	EP1729677A1 Graft material and stent graft comprising extra collagen matrix and method of preparation
12/13/2006	EP1729676A1 Pharmaceutical compositions for administration to a sinus
12/13/2006	EP1663154A4 i MAHONIA /i i AQUIFOLIUM /i EXTRACT, EXTRACTION PROCESS AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
12/13/2006	EP1549355B1 Method for the identification of sentinel lymph nodes
12/13/2006	EP1534370B1 Therapeutic aerosol device
12/13/2006	EP1478382B1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096
12/13/2006	EP1478372B1 Long acting parasiticidal composition containing a salicylanilide compound, a polymeric species and at least one other anti-parasitic compound
12/13/2006	EP1397132A4 Pirenzepine ophthalmic gel
12/13/2006	EP1372737B8 Preparation for the prophylaxis of restenosis
12/13/2006	EP1328252B1 Transdermal pharmaceutical delivery composition
12/13/2006	EP1289487B1 Pre-formed sheet devices suitable for topical application
12/13/2006	EP1248598B1 Osmotic device having a preformed passageway that increases in size
12/13/2006	EP1216042B1 Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles
12/13/2006	EP1143896B1 Methods of hydrating the nasal mucosal surface
12/13/2006	EP0875251B1 Therapeutic agent for treatment of fiv infections
12/13/2006	EP0678035B9 Vaccine preparations
12/13/2006	CN2845833Y Magnetic therapeutic medicinal plaster
12/13/2006	CN2845802Y Carrier suppository for women
12/13/2006	CN1878602A Manufacturing method of organic compound particulate
12/13/2006	CN1878571A Polysaccharide-containing composition and lacrimal fluid layer-stabilizing instillation
12/13/2006	CN1878570A Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
12/13/2006	CN1878563A Pharmaceutical compositions including low dosages of desmopressin
12/13/2006	CN1878559A Desensitization of compliment activation using monocyte/macrophage inhibitory compounds
12/13/2006	CN1878549A Percutaneous absorption type cerebral protective agent
12/13/2006	CN1878545A Thyroid hormone analogs and methods of use
12/13/2006	CN1878543A Enteric delivery of (-)-hydroxycitric acid
12/13/2006	CN1878542A Non-tabletted, chewable, individually dosed administration forms
12/13/2006	CN1878541A Microparticles comprising somatostatin analogues
12/13/2006	CN1878540A Taste masked pharmaceutical composition comprising pH sensitive polymer
12/13/2006	CN1878539A Taste masked pharmaceutical compositions comprising bitter drug and pH sensitive polymer
12/13/2006	CN1878538A Solid amorphous dispersions of an MTP inhibitor for treatment of obesity
12/13/2006	CN1878537A Dry powder formulations
12/13/2006	CN1878536A Antimicrobial compositions and methods
12/13/2006	CN1876642A Cnidium fruit essence crystal and preparation method and uses
12/13/2006	CN1876185A Biodegradable hyaluronic acid derivative and composition containing micelles made therefom
12/13/2006	CN1876181A Weak toxicity united vaccine formulation for canidae animal important disease series and preparation process
12/13/2006	CN1876178A Granule with beauty and health function
12/13/2006	CN1876177A Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses
12/13/2006	CN1876175A Neurotrophic factor slow release nanometer formulation and its preparation method and uses
12/13/2006	CN1876174A Pharmaceutical combination containing kuhseng element and thymus pentapeptide and preparation method thereof
12/13/2006	CN1876173A Thymus pentapeptide slow-release microshpere formulation for injection and its preparation method
12/13/2006	CN1876167A Medicine for treating chronic bronchitis and its preparation method
12/13/2006	CN1876166A Externally applied medicine for stopping hair shed and generating hair and its preparation method
12/13/2006	CN1876165A Traditional Chinese medicine formulation for treating diarrhea
12/13/2006	CN1876163A Navel-adhibitting medicine for vomit-stopping in chemotherapy
12/13/2006	CN1876162A Plaster for treating orthopaedic diseases and its preparation process
12/13/2006	CN1876161A Pharmaceutical formulation and preparing method for breast nodules for treating hyperplasia of mammary glands, and its quality control method
12/13/2006	CN1876159A Preparation method for preparing traditional Chinese medicine for treating tumour, and the prepared traditional Chinese medicine

1 ... 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 ... 2991